CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Charlotte, North Carolina, United States and 32 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Charlotte, North Carolina, United States and 208 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Charlotte, North Carolina, United States and 225 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
Mooresville, North Carolina, United States and 60 other locations
(IV) infusion of ocrelizumab in patients with either relapsing multiple sclerosis (RMS) or primary progressive multiple sc...
Phase 3
Hickory, North Carolina, United States and 37 other locations
in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...
Phase 3
Charlotte, North Carolina, United States and 34 other locations
Primary Objective:To determine the efficacy of SAR441344 as measured by reduction of the number of new active brain lesionsSecondary Objective:To eva...
Phase 2
Charlotte, North Carolina, United States and 37 other locations
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...
Phase 3
Charlotte, North Carolina, United States and 30 other locations
relapse rate (ARR) in participants with relapsing forms of MSSecondary Objective:To assess efficacy of SAR442168 compared to teriflunomide (...
Phase 3
Charlotte, North Carolina, United States and 185 other locations
A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple...
Phase 3
Charlotte, North Carolina, United States and 192 other locations
Clinical trials
Research sites
Resources
Legal